Oral suspension of prednisolone acetate

Details for Australian Patent Application No. 2006278620 (hide)

Owner Taro Pharmaceuticals North America, Inc.

Inventors Yacobi, Avraham; Gao, Shen; Asotra, Satish

Agent Griffith Hack

Pub. Number AU-B-2006278620

PCT Pub. Number WO2007/019184

Priority 60/705,370 04.08.05 US

Filing date 3 August 2006

Wipo publication date 15 February 2007

Acceptance publication date 2 February 2012

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/019184 Priority application(s): WO2007/019184

2 February 2012 Application Accepted

  Published as AU-B-2006278620

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006278622-Method for treating skin irritations such as diaper rash and the like

2006278618-Methods and systems for high confidence utilization of datasets